Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-02

Clinical Trial Update: The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating fibrinogen concentrate infusion on blood loss and allogeneic blood conservation in scoliosis surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Scoliosis; Adolescence, Bleeding | Phase 4 | Status: COMPLETED